Amitriptyline is used to treat depression by increasing amounts of certain natural chemicals in the brain needed for mental balance. It belongs to a class of older antidepressants and may also be used for nerve pain, eating disorders, and migraine prevention.[2] Elavil is currently approved and in use across 25 indications[4].[1]
Elavil is one of 438 small molecule programs targeting Diabetic Neuropathy. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
105 competitors in Migraine
Elavil
Zonegran
Magnesium
Triptans
Aspirin /d
BAT7104
Flunarizine
Tizanidine Hydrochloride
Bayer Aspirin
Cymbalta
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
ELAVIL
NDA NDA012704
Jan 1, 1982
ELAVIL
NDA NDA012703
Sources
Details